ALG-097558
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ALG-097558, covering 2025-04-08 to 2026-08-05. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function [Phase 1]